7 results match your criteria: "National Center on Birth Defects and Development Disabilities[Affiliation]"

Background: Cleft lip with cleft palate (CLP) is a congenital condition that affects both the oral cavity and the lips. This study estimated the prevalence and mortality of CLP using surveillance data collected from birth defect registries around the world.

Methods: Data from 22 population- and hospital-based surveillance programs affiliated with the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR) in 18 countries on live births (LB), stillbirths (SB), and elective terminations of pregnancy for fetal anomaly (ETOPFA) for CLP from 1974 to 2014 were analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed data from various birth defect surveillance programs across 18 countries to assess the prevalence and mortality rates of anorectal malformation (ARM) between 1974 and 2014.
  • The overall prevalence of ARM was found to be 3.26 cases per 10,000 births, with a notable decrease in cases that were multiple, syndromic, or stillborn from 2001 to 2012.
  • The research highlights a significant mortality risk during the first week of life, especially in multiple and syndromic cases, suggesting a need for tailored clinical services and further investigation into factors affecting ARM prevalence and mortality.
View Article and Find Full Text PDF

Prevalence and mortality in children with congenital diaphragmatic hernia: a multicountry study.

Ann Epidemiol

April 2021

Arkansas Center for Birth Defects Research and Prevention and Arkansas Reproductive Health Monitoring System and Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR. Electronic address:

Purpose: This study determined the prevalence, mortality, and time trends of children with congenital diaphragmatic hernia (CDH).

Methods: Twenty-five hospital- and population-based surveillance programs in 19 International Clearinghouse for Birth Defects Surveillance and Research member countries provided birth defects mortality data between 1974 and 2015. CDH cases included live births, stillbirths, or elective termination of pregnancy for fetal anomalies.

View Article and Find Full Text PDF

Background: Medical advancements have resulted in better survival and life expectancy among those with spina bifida, but a significantly increased risk of perinatal and postnatal mortality for individuals with spina bifida remains.

Objectives: To examine stillbirth and infant and child mortality among those affected by spina bifida using data from multiple countries.

Methods: We conducted an observational study, using data from 24 population- and hospital-based surveillance registries in 18 countries contributing as members of the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR).

View Article and Find Full Text PDF

Venous thromboembolism as a cause of severe maternal morbidity and mortality in the United States.

Semin Perinatol

June 2019

Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.

In the U.S., deaths due to pulmonary embolism (PE) account for 9.

View Article and Find Full Text PDF

The present study describes positive and negative interference of human cytokine measurement in multiplexed bead-based immunoassays. Significant differences in measured IL-6 and TNF-alpha values in 30 normal human plasma samples were apparent depending on whether measurements were with a 2-plex assay or embedded in a multiplex of 8-or more cytokine antibody pairs, as well as among the kits of 3-different vendors. Sample diluents containing proprietary blocking ingredients were shown to greatly affect the outcome of measured cytokine values.

View Article and Find Full Text PDF

Given the rapidly growing area of molecular genetic laboratory testing, we sought to assess changing issues over a 2-year period of time pertaining to the availability of testing for GJB2 mutations associated with non-syndromic hearing loss. Laboratory assessments carried out by telephone interviews with directors or other key personnel revealed variations among laboratories in informed consent practices, evaluation of test requests for appropriateness, and the reporting of results. From 1999 to 2000, referral patterns shifted as did sources for reimbursement, policies regarding evaluation of incoming test requests, and reporting procedures.

View Article and Find Full Text PDF